CClinicalTrials.gg
TerminatedNCT03437460Updated Aug 3, 2018

The Economic and Cognitive Effects of Pain Reduction

An interventional study of Ibuprofen 600 mg and Prenatal vitamins in Pain, Chronic, sponsored by University of Pennsylvania. Terminated at 1 site in India. Open to female participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-08-03.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Treatment

Why this study was terminated
Implementation issues
Phase
Not applicable
Study type
Interventional
Enrollment
139
Allocation
Randomized
Ages
25 Years to 65 Years
Sex
Female
01

Study summary

Physical pain is a common but largely overlooked aspect of the lives of the poor. Not only does pain directly reduce life quality and happiness, it may also hamper cognitive function and, consequently, decision-making, productivity, and earnings. Workers with chronic pain may work fewer days, take longer breaks, and make less-considered choices regarding inputs; all outcomes that would reduce output and lead to greater impoverishment or impede the productivity and profitability of microenterprises and firms. The investigators will take the first steps in understanding the broader causal impact of physical pain on the cognitive and economic lives of the poor via a randomized controlled trial (RCT). 450 low-income women in Chennai, India, will be assigned to one of three treatment arms: 600 mg of over-the-counter pain medication, a placebo pill, or no medication. The research will quantify the causal impact of reduced pain on previously unstudied outcomes essential to escaping poverty including cognitive function, productivity, and earnings.

Read the detailed description

The investigators propose to evaluate the effect of reductions in chronic physical pain on cognitive function and productivity among poor individuals via a simple intervention using over-the-counter (OTC) pain medication. To do this, the investigators will enroll 450 low-wage female workers in Chennai, India into a two-day randomized controlled trial in which 150 randomly selected participants will receive OTC Non-steroidal Anti-inflammatory Drugs (NSAIDs; namely, Ibuprofen) at FDA-approved levels of one dose of 600 mg each on a single day, 150 participants will receive a placebo pill, and 150 participants will serve as a no-treatment control group.

Participants will complete a detailed survey, a battery of cognitive tests, pain measurements, a task to objectively scale each participant's pain assessments, and a task designed to measure economic productivity as detailed below.

Study location:

The study will be based at the Behavioral and Development Economics Lab in Chennai, India, founded by PIs Schofield and Schilbach in conjunction with a local institution, the Institute for Financial Management and Research (IFMR).

Sample:

Participants will consist of female flower stringers in Chennai, India. Flower stringers are self-employed individuals typically working on the streets. These women purchase flowers in the morning, string them together, and sell the strands to customers passing by. Their average daily income is Rs. 250-500 (approximately $4-9). Preliminary survey evidence suggests a higher prevalence of physical pain among older individuals; hence, this study will limit enrollment to individuals aged 25 to 65 years. The investigators focus on this population for several additional reasons. First, the nature of their work (stringing flowers while sitting on the floor for most of the day) causes high levels of pain. Second, due to the societal norms in the area, women do not regularly consume significant amounts of alcohol, substantially lowering the risks associated with taking pain medication. Third, the nature of their work makes flower stringers' productivity easily measurable (length and weight of flowers strung). Finally, although this population is specific, participants are similar in many ways (e.g. age, education, labor habits) to many workers in the informal sector, improving the study's external validity.

Recruitment and screening:

Surveyors approach potential participants at their place of work (typically a stand on the side of the street). The surveyor shares information about the study, while also conducting a broad first screen for eligibility. If participants are interested in participating and pass the initial screening, they schedule a time to come in to the lab for Day 1 (see below for further detail on the timing of the study). On Day 1, all potential participants are further screened to ensure: 1) their primary profession is flower-stringing, 2) they do not have any health conditions which are contraindicated for taking ibuprofen, 3) they regularly experience pain from their work, and 4) they are between the ages of 25 and 65.

Timing:

Day 1: Following field recruitment, potential participants are screened for eligibility and complete an informed consent process. If eligible, participants complete the survey measuring demographics, work habits, and data on the type and amount of pain typically experienced. Participants also complete the battery of cognitive assessments.

The investigators will randomize using Stata and then reveal the experimental condition assignment to individuals privately. Any non-compliance will be carefully tracked.

Day 2: Participants complete the battery of cognitive tasks and 30 minutes of flower stringing in the morning (pre-treatment). Participants report their pain levels periodically and complete a "pain calibration" by reporting their pain levels while holding their hand in cold water. They are then randomly assigned to one of the three experimental arms at lunch. After lunch, all participants complete another 3 hours of flower-stringing and repeat the battery of cognitive tasks. Participants also complete a "pain tolerance test" after lunch. In this task, participants are paid for the time they leave their hand in cold water.

02

Conditions studied

  • Pain, Chronic

Browse trials for

Keywords

  • Productivity
  • Cognitive Function
  • Decision Making
  • Well-Being
  • Health
  • Labor
03

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Must be between the ages of 25 and 65
  • Must speak Tamil as their primary language
  • Must report that they have suffered from chronic physical pain in the last week.

Exclusion criteria

Exclusion Criteria:

  • An adverse relation related to pain medication in the past
  • Kidney disease (ongoing or kidney stone within the past 3 years)
  • Gastrointestinal (GI) discomfort
  • History of complicated peptic ulcer disease
  • Currently using NSAIDs, aspirin, corticosteroids or anticoagulants
  • Allergies to any of the medicines use in the study
  • History of gastric bleeding
  • History or existing liver disease
  • Surgery within 1 to 2 weeks after the study
  • Hypertension
  • Heart disease or failure
  • Diabetes
  • Lupus
  • Blood clotting
  • Actual or potential pregnancy
  • Use of contraindicated medications (including anticoagulants)
  • Suicidal thoughts
  • Consumption of more than 14 alcoholic beverages a week.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
139 participants (actual)

Study arms

  • Active comparator
    Ibuprofen 600mg

    Treatment group participants receive a single 600 mg of over-the-counter ibuprofen.

    Drug: Ibuprofen 600 mg

  • Placebo comparator
    Prenatal vitamins

    The placebo group participants receive a single dose of a pre-natal multivitamin.

    Dietary Supplement: Prenatal vitamins

  • No intervention
    Control group

    Control-group participants are not provided with any treatment and they are fully informed regarding their treatment status.

Interventions

  • DrugIbuprofen 600 mg

    The investigators administer one single 600 mg dose of ibuprofen immediately before lunch. Participants are then asked to complete the cold pressor task, flower stringing sessions, and cognitive tasks.

    Also known as: Brufen

  • Dietary supplementPrenatal vitamins

    The investigators administer one single prenatal multivitamin immediately before lunch. Participants are then asked to complete the cold pressor task, flower stringing sessions, and cognitive tasks.

05

What researchers measure

Primary outcomes

  1. Change in pain levels - visual analog scale

    Visual analog scale pain levels will measure the participant's self-assessed pain levels throughout the day. On the morning of Day 2 of the study, visual analog scale pain levels are recorded after each of the 4 cognitive tasks and after 30 minutes of flower stringing. Visual analog scale pain levels are reported throughout the afternoon of study Day 2 after each cognitive task and after every 30 minutes of flower stringing, and then compared to the baseline measures.

    Time frame: Change from baseline to end of Day 2

  2. Change in pain levels - cold pressor task

    Cold pressor task will measure the participant's pain tolerance. To assess a baseline tolerance, participants are asked to place their hand in cold water for 5 seconds to become accustomed to the task, and then for 20 seconds, after which they report their pain level. After lunch, participants complete the cold pressor duration, during which they hold their hand in cold water for as long as they want, up to 2 minutes. This measure is compared to the baseline measure from the morning.

    Time frame: Change from baseline to end of Day 2

  3. Change in cognitive function: impulse control

    The Hearts and Flowers task is completed once in the morning as a baseline measure and twice in the afternoon, to compare to the baseline. The task is compensated according to performance.

    Time frame: Change from baseline to end of Day 2

  4. Change in cognitive function: simple memory

    The Corsi block-span task is completed once in the morning as a baseline measure and twice in the afternoon, to compare to the baseline. The task is compensated according to performance.

    Time frame: Change from baseline to end of Day 2

  5. Change in cognitive function: working memory

    The N-back task is completed once in the morning as a baseline measure and twice in the afternoon, to compare to the baseline. The task is compensated according to performance.

    Time frame: Change from baseline to end of Day 2

  6. Change in cognitive function: simple attention

    The Psychomotor Vigilance is completed once in the morning as a baseline measure and twice in the afternoon, to compare to the baseline. The task is compensated according to performance.

    Time frame: Change from baseline to end of Day 2

  7. Change in flower-stringing productivity: weight of flower buds used

    Flower stringing productivity (weight of buds used) baseline is measured in the morning after a 30 minute flower stringing session. This outcome is compared to the weight of flower buds used in the afternoon flower stringing sessions, which span 150 minutes and 30 minutes.

    Time frame: Change from baseline to end of Day 2

  8. Change in flower-stringing productivity: length of garland

    Flower stringing productivity (length of garland) baseline is measured in the morning after a 30 minute flower stringing session. This outcome is compared to the length of garland in the afternoon flower stringing sessions, which span 150 minutes and 30 minutes.

    Time frame: Change from baseline to end of Day 2

  9. Change in flower-stringing productivity: density of garland

    Flower stringing productivity (density of garland) baseline is measured in the morning after a 30 minute flower stringing session. This outcome is compared to the density of garland in the afternoon flower stringing sessions, which span for 150 minutes and then for 30 minutes.

    Time frame: Change from baseline to end of Day 2

06

Study locations

1 site
  • Institute for Financial Management and Research
    Chennai, Tamil Nadu 600034, India
07

References and documents

Study documents

  • Informed consent form · May 24, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified data will be made available to other researchers upon request.

Supporting information: Study protocol, Icf

08

Registry details

Key details

Study ID
NCT03437460
Lead sponsor
University of Pennsylvania
Collaborators
Institute for Financial Management and Research
Responsible party
Heather Schofield (Assistant Professor, University of Pennsylvania) — Principal investigator
First posted
Feb 19, 2018
Start date
May 10, 2017
Primary completion
Aug 12, 2017
Completion
Aug 12, 2017
Last update
Aug 3, 2018

Study contacts

Frank Schilbach, Ph.D.
principal investigator · MIT Department of Economics
Heather Schofield, Ph.D.
principal investigator · University of Pennsylvania, Perelman School of Medicine and Wharton Business School
Anuj Shah, Ph.D.
principal investigator · University of Chicago, Booth School of Business
Sendhil Mullainathan, Ph.D.
principal investigator · Harvard University
Emma Dean, M.S.
principal investigator · University of Pennsylvania, Wharton School of Business

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion